|
Dr. Mihich is Distinguished Member of Experimental Therapeutics at the Grace Cancer Drug Center, Roswell Park Cancer Institute, and Professor and Chairman of Molecular Pharmacology at the State University of New York at Buffalo.
Dr. Mihich has been affiliated with the Roswell Park Cancer Institute since 1957 and prior to his current position was Director of the Department of Experimental Therapeutics and of the Grace Cancer Drug Center for 30 years. He is a past President of the American Association of Cancer Research (AACR) and a member of the National Cancer Advisory Board. Dr. Mihich has served on the editorial boards of sixteen scientific journals and has published his own work in more than 130 articles.
He earned his medical degree from the University of Milan, Italy and was a visiting research fellow at the Sloan-Kettering Institute for Cancer Research. | 